查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018487

磁振造影血管血管造影術市場：依產品、磁場強度、技術、應用和最終用戶分類－2026-2032年全球市場預測

Magnetic Resonance Angiography Market by Product, Field Strength, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，磁振造影血管造影術(MRA) 市值將達到 35.6 億美元，到 2026 年將成長至 39.2 億美元，到 2032 年將達到 76.7 億美元，複合年成長率為 11.57%。

主要市場統計數據
基準年 2025 35.6億美元
預計年份：2026年 39.2億美元
預測年份 2032 76.7億美元
複合年成長率 (%) 11.57%

本文簡要概述了磁振造影血管造影術(MRA) 的最新創新如何與臨床需求、營運重點和組織決策相交。

磁振造影血管血管造影術（MRA）處於影像創新與血管治療路徑的關鍵交會點，為臨床醫師在各種臨床環境中提供非侵入性的血管可視化手段。近年來，技術的進步降低了操作的複雜性，拓展了其臨床應用範圍，並提高了患者的舒適度，使MRA從小眾影像技術發展成為許多血管治療流程中的核心診斷工具。這些進步得益於定序技術的創新、硬體的進步以及軟體驅動的影像重建，它們重新定義了臨床醫生的期望和採購重點。

對正在重新定義磁振造影血管造影術的實踐和實施的硬體、定序和計算技術趨勢進行詳細分析。

在磁振造影血管攝影（MRA）領域，硬體、脈衝序列設計和計算影像處理的進步融合正在帶來變革性的轉變。高場系統不斷突破信噪比的極限，實現更高的空間解析度；同時，低場系統的同步發展也因其整體擁有成本更低、更易於操作等優勢而重新引起人們的關注。此外，諸如飛行時間法和靜止間隔單次激發法等造影劑技術日益成熟，減少了對钆基造影劑的依賴，並重塑了腎功能不全患者和需要重複成像患者的臨床方案。

評估美國 2025 年的新關稅措施將如何影響整個磁振造影血管造影術(MRA) 生態系統的籌資策略、供應鏈和資本規劃。

美國2025年實施的新關稅將為互認協議（MRA）的相關人員帶來複雜的環境，影響採購週期、採購決策和供應商關係。關稅帶來的成本壓力可能會推高進口零件和完整影像系統的到貨價格，進而影響醫院、診斷中心和門診機構的資金配置和升級計畫。面對不斷上漲的採購成本，許多買家可能會推遲升級，或優先考慮可分階段實施的模組化投資。同時，一些買家可能會更仔細地審查總擁有成本（TCO），包括維護和耗材供應合約。

詳細的細分分析揭示了產品類型、市場規模層級、影像技術、臨床應用和最終用戶概況如何全面影響 MRA 的需求和投資。

對市場區隔的深入理解揭示了臨床需求和投資在整個磁振造影血管攝影（MRA）市場的交匯點。依產品分析市場，可以清楚看到配件、耗材、持續服務合約和資本設備系統之間的價值流動。系統本身也分為高場強和低場強平台，每個平台都提供不同的臨床功能和生命週期經濟效益。即使僅按場強進行細分，這種二分性也同樣存在，高場強和低場強平台分別對應不同的臨床應用場景和醫療預算。基於技術的細分錶明，造影增強方法與相位對比調查方法、靜態間隔單次成像和飛行時間成像並存，每種方法都具有獨特的診斷優勢和特定的序列工作流程要求。

一項全面的區域分析，顯示了美洲、歐洲、中東和非洲以及亞太地區在MRA的採用模式、採購趨勢和臨床重點方面的差異。

區域趨勢對全球MRA市場整體影響顯著，進而影響技術應用、報銷機制與臨床實務模式。在美洲，臨床網路和大規模醫療系統往往推動高效能系統和先進定序文庫的早期應用，而支付方模式和醫院資金籌措方式的差異則導致採購節奏的顯著差異。歐洲、中東和非洲既有成熟的市場（擁有完善的報銷機制），也有新興的醫療系統（優先考慮成本效益高且擴充性的解決方案）。監管協調和跨境臨床合作的努力進一步塑造了這些地區的需求。在亞太地區，都市區的應用速度很快，這得益於診斷基礎設施的擴展和對非侵入性血管診斷投資的增加。然而，高所得大都會圈和資源匱乏地區之間的市場成熟度差異很大，在資源匱乏地區，低場系統和更有效率的服務模式可能更具實用性。

一項策略性競爭分析，重點在於決定磁振造影血管血管造影術(MRA) 市場供應商成功的整合硬體、軟體和服務提案。

在磁振造影血管攝影（MRA）生態系統中，競爭格局的格局正日益不再取決於單一設備的銷售，而是取決於整合硬體、定序庫、後處理軟體和服務合約的整合解決方案。能夠為系統提供強大的軟體工具包（用於血管分割、血流定量和人工智慧增強重建）的原始設備製造商（OEM）正在大規模醫療保健系統中佔據更有利的地位，這些系統優先考慮互通性和清晰的藍圖。同時，專注於耗材、線圈和手術配件的供應商則在臨床適用性、易於整合性和可預測的供應鏈方面競爭。提供快速維護、遠距離診斷和靈活培訓計劃的服務供應商正在為尋求正常運作和提升員工能力的終端使用者創造實際價值。

為產業領導者提供實用的策略框架，以最佳化 MRA 解決方案的技術投資、供應鏈、臨床檢驗和商業化。

產業領導者應採取多管齊下的策略，加速在所有醫療機構推廣MRA技術，同時提升臨床價值並降低外部風險。首先，應優先投資於定序和軟體開發，以顯著縮短掃描時間並提高診斷可靠性，從而增強臨床投資回報率。同時，應實現供應鏈多元化，並探索區域製造或組裝夥伴關係關係，以降低關稅風險並縮短前置作業時間。這些營運措施應輔以靈活的經營模式，將資本投資與基本服務和軟體收入脫鉤，為採購者提供符合其預算和臨床安排的客製化選擇。

我們將以透明的方式解釋我們的混合方法研究方法，該方法結合了第二手資料審查、一手訪談和嚴格的檢驗，以確保對MRA有可靠的見解。

本研究整合了透過混合方法收集的研究結果，該方法強調三角檢驗和相關人員核實。次要分析包括對同行評審的臨床文獻、技術白皮書、監管申報文件和公共採購文件進行系統性回顧，揭示了序列開發、磁場強度利用和臨床實踐的趨勢。主要研究包括對客觀選取的放射科醫生、血管外科醫生、放射技師、醫院採購負責人和影像服務提供者的高級管理人員進行結構化訪談和討論，以確保涵蓋臨床、營運和商業領域的多元化觀點。

技術、臨床和操作因素的整合將決定磁振造影血管造影術（MRA）能否實現更廣泛的臨床整合和永續的價值創造。

磁振造影血管血管造影術（MRA）正處於技術創新、臨床需求和經濟壓力交會的十字路口。高場和低場系統的進步、無造影和造影增強技術的改進以及人工智慧重建技術的整合，正在拓展該技術的臨床應用範圍。同時，費用調整、供應鏈重組和區域採購條件等結構性因素正在重塑各機構實施和部署MRA功能的方式。這些雙重力量既為價值創造提供了機遇，也使得策略調整至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 磁振造影血管血管造影術市場：依產品分類

  • 配件和耗材
  • 服務
  • 系統
    • 高磁場強度系統
    • 低磁場強度系統

第9章：以磁場強度分類的磁振造影血管造影術市場

  • 高磁場強度
  • 低磁場強度

第10章 磁振造影血管血管造影術市場：依技術分類

  • 造影的使用
  • 相襯
  • 單次射擊，休息間隔
  • 飛行時間法

第11章 磁振造影血管血管造影術市場：依應用領域分類

  • 心血管系統
  • 神經血管
  • 周邊血管

第12章 磁振造影血管血管造影術市場：依最終用戶分類

  • 學術研究機構
  • 門診手術中心
  • 診斷影像中心
  • 醫院

第13章 磁振造影血管血管造影術市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 磁振造影血管血管造影術市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 磁振造影血管血管造影術市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國磁振造影血管造影術市場

第17章：中國磁振造影血管造影術市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ASG Superconductors SpA
  • Aspect Imaging Ltd.
  • Aurora Imaging Technologies, Inc.
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Esaote SpA
  • Fonar Corporation
  • Fujifilm Holdings Corporation
  • GE Healthcare, Inc.
  • Hitachi, Ltd.
  • Hologic, Inc.
  • Hyperfine, Inc.
  • Koninklijke Philips NV
  • Neusoft Medical Systems Co., Ltd.
  • Oxford Instruments plc
  • Samsung Medison Co., Ltd.
  • Shenzhen Anke High-tech Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Time Medical Holding Co., Ltd.
  • United Imaging Healthcare Co., Ltd.
  • Wandong Medical Equipment Co., Ltd.
Product Code: MRR-A339DAEFA1A0

The Magnetic Resonance Angiography Market was valued at USD 3.56 billion in 2025 and is projected to grow to USD 3.92 billion in 2026, with a CAGR of 11.57%, reaching USD 7.67 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.56 billion
Estimated Year [2026] USD 3.92 billion
Forecast Year [2032] USD 7.67 billion
CAGR (%) 11.57%

Concise framing of how modern magnetic resonance angiography innovations intersect with clinical needs, operational priorities, and organizational decision-making

Magnetic resonance angiography (MRA) occupies a critical nexus between diagnostic imaging innovation and vascular care pathways, offering clinicians noninvasive visualization of blood vessels across a spectrum of clinical settings. Recent technological progress has reduced procedural complexity, expanded clinical indications, and improved patient comfort, thereby elevating MRA from a niche modality to a pivotal diagnostic tool in many vascular workflows. These developments, driven by sequence innovation, hardware evolution, and software-enabled image reconstruction, have reshaped clinician expectations and procurement priorities.

Consequently, stakeholders across imaging departments, clinical research units, and device manufacturing must reassess how MRA integrates with broader diagnostic strategies. Radiology teams are increasingly prioritizing throughput and diagnostic confidence, while hospital administrators seek modalities that support multi-disciplinary uses and predictable lifecycle costs. At the same time, ambulatory centers and diagnostic imaging providers are evaluating how MRA can enhance service portfolios without imposing unsustainable operational burdens. This introduction situates MRA within the contemporary clinical and commercial landscape, emphasizing the interplay between technological capability, clinical uptake, and organizational decision-making.

Detailed exploration of the converging hardware, sequence, and computational trends that are redefining magnetic resonance angiography practice and procurement

The MRA landscape is experiencing transformative shifts driven by converging advances in hardware, pulse-sequence design, and computational imaging. High-field systems continue to push signal-to-noise boundaries and enable higher spatial resolution, yet parallel progress in low-field systems has revived interest due to cost-of-ownership advantages and improved accessibility. Simultaneously, non-contrast techniques such as time-of-flight and quiescent interval single shot have matured to reduce reliance on gadolinium-based agents, reshaping clinical protocols for patients with renal impairment and those requiring repeated imaging.

In parallel, phase contrast sequences and advanced contrast-enhanced methods have been refined for hemodynamic assessments, facilitating more nuanced evaluation of vascular flow and lesion characterization. Artificial intelligence and machine learning now play an increasingly central role in reconstruction, denoising, and automated vessel segmentation, shortening scan times and enhancing diagnostic yield. As a result, service models and consumable workflows are adapting to support hybrid offerings that combine high-end systems, optimized sequence libraries, and value-added software. These shifts collectively redefine procurement criteria and clinical pathways, making interoperability, upgradeability, and software licensing as influential as baseline hardware specifications.

Assessment of how new 2025 tariff measures in the United States are reshaping procurement strategies, supply chains, and capital planning across the magnetic resonance angiography ecosystem

The introduction of new tariffs in the United States in 2025 creates a complex environment for MRA stakeholders, affecting procurement cycles, sourcing decisions, and supplier relationships. Tariff-related cost pressures can raise the landed price of imported components and finished imaging systems, which in turn influences capital allocation and replacement timelines for hospitals, diagnostic centers, and ambulatory facilities. Faced with higher acquisition costs, many purchasers may defer upgrades or prioritize modular investments that can be staged over time, while others will scrutinize total cost of ownership more intensely, including maintenance contracts and consumable supply agreements.

Furthermore, tariff policies incentivize strategic supplier diversification and nearshoring, prompting manufacturers to reconfigure supply chains to mitigate exposure to tariff volatility. For service providers and consumable suppliers, tariffs may alter competitive dynamics as local production becomes relatively more attractive. In this context, procurement teams and clinical leaders must factor supply chain resilience into sourcing criteria, balancing potential short-term cost savings against the risks of single-source dependencies. Regulatory compliance and customs optimization will therefore assume greater importance, and stakeholders should be prepared to engage suppliers on inventory planning and contract flexibility to absorb episodic tariff impacts. Taken together, these adjustments will shape capital planning, vendor negotiations, and operational continuity throughout the imaging ecosystem.

In-depth segmentation synthesis revealing how product types, field strength tiers, imaging technologies, clinical applications, and end-user profiles collectively shape MRA demand and investment

A granular understanding of market segmentation illuminates where clinical demand and investment converge across the MRA landscape. When the market is parsed by product, distinct value streams emerge between accessories and consumables, ongoing service arrangements, and capital systems, with systems themselves bifurcating into high field strength and low field strength platforms that deliver different clinical capabilities and lifecycle economics. This dichotomy is mirrored when segmentation is organized by field strength alone, as high field strength and low field strength platforms each address separate clinical use cases and institutional budgets. Technology-based segmentation reveals how Contrast Enhanced procedures coexist alongside Phase Contrast methodologies, Quiescent Interval Single Shot techniques, and Time Of Flight approaches, each contributing unique diagnostic strengths and sequence-specific workflow requirements.

Application-focused segmentation further clarifies clinical trajectories, with cardiovascular applications encompassing both aortic and cardiac imaging needs, neurovascular practice differentiating between extracranial and intracranial indications, and peripheral vascular use cases delineating imaging of lower limb and upper limb territories. These clinical partitions interact with end-user categories, including academic research institutes, ambulatory surgical centers, diagnostic imaging centers, and hospitals, which vary markedly in procurement cycles, clinical throughput expectations, and staffing models. Consequently, product, field strength, technology, application, and end-user segments create overlapping demand pockets; by tracing these intersections, stakeholders can prioritize investments, tailor service offerings, and design clinical validation studies that resonate with the operational realities of each segment.

Comprehensive regional analysis showing how Americas, Europe Middle East & Africa, and Asia-Pacific each present distinct adoption patterns, procurement dynamics, and clinical priorities for MRA

Regional dynamics exert a profound influence on technology adoption, reimbursement frameworks, and clinical practice patterns across the global MRA landscape. In the Americas, clinical networks and large health systems often drive early adoption of high-performance systems and advanced sequence libraries, while variations in payer models and hospital funding introduce distinct procurement rhythms. Europe, Middle East & Africa present a heterogeneous mix of mature markets with established reimbursement pathways alongside emerging healthcare systems that prioritize cost-effective, scalable solutions; regulatory harmonization efforts and cross-border clinical collaborations further shape demand in these territories. Asia-Pacific exhibits rapid uptake in urban centers driven by expanding diagnostic infrastructures and increasing investment in noninvasive vascular diagnostics, yet market maturation varies widely between high-income metropolitan areas and resource-constrained regions where low-field systems and streamlined service models may be more practical.

Across these geographies, differences in clinical guidelines, training pipelines, and service delivery models influence how MRA is positioned relative to alternative imaging modalities. Vendors and service providers should therefore adopt region-specific engagement strategies that account for procurement cycles, local clinical champions, and regional regulatory considerations. Moreover, partnerships with regional research institutions and targeted clinical education programs can accelerate adoption where clinical demand and capacity align, while flexible commercial models can help bridge gaps in regions with constrained capital availability.

Strategic competitive analysis highlighting how integrated hardware, software, and service propositions determine vendor success in magnetic resonance angiography markets

Competitive dynamics in the MRA ecosystem are increasingly defined by integrated offerings that combine hardware, sequence libraries, post-processing software, and service contracts rather than standalone equipment sales. Original equipment manufacturers who can complement systems with robust software toolkits for vessel segmentation, flow quantification, and AI-enhanced reconstruction secure stronger footholds among large health systems that prize interoperability and roadmap clarity. Simultaneously, specialist vendors focused on consumables, coils, and procedural accessories compete on the basis of clinical compatibility, ease of integration, and predictable supply chains. Service providers that deliver responsive maintenance, remote diagnostics, and flexible training programs add tangible value for end users seeking uptime assurance and staff competency.

Strategic partnerships between imaging IT providers and clinical networks are also emerging as a differentiator, enabling longitudinal data analytics and quality improvement initiatives that extend the clinical utility of MRA. In this environment, companies that invest in clinical validation, provide transparent upgrade paths, and demonstrate strong regulatory compliance are better positioned to win complex, multi-stakeholder procurement decisions. For smaller firms, focusing on niche clinical applications, compelling economic value propositions, or novel contrast and non-contrast techniques can create defensible market positions. Ultimately, success rests on aligning product and service innovations with the operational realities of diverse clinical environments while managing supply chain and tariff-related risks through adaptive sourcing strategies.

Actionable strategic framework for industry leaders to optimize technology investments, supply chains, clinical validation, and commercialization of MRA solutions

Industry leaders should pursue a multi-pronged strategy to capture clinical value and mitigate external risks while accelerating MRA adoption across care settings. First, prioritize investments in sequence and software development that materially reduce scan time and enhance diagnostic confidence, enabling stronger clinical ROI narratives. Concurrently, diversify supply chains and explore regional manufacturing or assembly partnerships to buffer tariff exposure and improve lead times. These operational moves should be complemented by flexible commercial models that decouple capital acquisition from essential service and software revenues, giving purchasers options that align with their budget and clinical schedules.

Second, cultivate clinical evidence through targeted validation studies that demonstrate comparative performance across key use cases such as aortic imaging, cardiac vascular assessment, intracranial lesion characterization, and peripheral limb evaluation. Third, invest in training and change management programs to ensure radiology teams and technologists can extract maximum diagnostic value from new sequences and AI-based tools. Fourth, develop region-specific go-to-market plans that reflect reimbursement realities, regulatory nuances, and the varying adoption curves of high field versus low field systems. Finally, engage proactively with payers, health systems, and clinical societies to articulate the clinical and economic value of MRA-based pathways, thereby creating a supportive environment for sustainable adoption and scale.

Transparent description of the mixed-methods research approach combining secondary review, primary interviews, and rigorous validation to ensure reliable MRA insights

This research synthesizes insights gathered through a mixed-methods approach that emphasizes triangulation and stakeholder validation. Secondary analysis included a systematic review of peer-reviewed clinical literature, technical whitepapers, regulatory filings, and public procurement documentation to establish trends in sequence development, field strength utilization, and clinical practice. Primary research comprised structured interviews and consultations with a purposive sample of radiologists, vascular surgeons, imaging technologists, hospital procurement officers, and senior executives from imaging providers, ensuring diverse perspectives across clinical, operational, and commercial domains.

Quantitative and qualitative data were integrated through thematic coding and comparative analysis, with particular attention paid to sequence performance metrics, operational constraints, and purchasing considerations. Findings were validated through follow-up discussions with clinical and procurement stakeholders to confirm practical relevance and to calibrate interpretations against real-world workflows. Throughout the process, care was taken to anonymize primary-source inputs and to document methodological assumptions, enabling reproducibility and transparency. Limitations and potential biases are acknowledged, and areas identified for further primary study are noted to guide subsequent research investments.

Synthesis of technological, clinical, and operational factors that will determine whether magnetic resonance angiography achieves broader clinical integration and sustained value creation

Magnetic resonance angiography sits at an inflection point where technical innovation, clinical demand, and economic pressures converge. Advancements in both high-field and low-field systems, refinements in non-contrast and contrast-enhanced techniques, and the integration of AI-driven reconstruction are collectively expanding the modality's clinical applicability. At the same time, structural factors such as tariff changes, supply chain reconfiguration, and regional procurement idiosyncrasies are reshaping how organizations acquire and deploy MRA capabilities. These dual forces create both opportunities for value creation and imperatives for strategic adaptation.

Looking ahead, stakeholders that align product development with demonstrable clinical outcomes, maintain flexible sourcing strategies, and invest in clinician training will be best positioned to translate technological potential into routine clinical benefit. Cross-disciplinary collaboration between device manufacturers, clinical teams, and imaging IT providers will accelerate the realization of advanced vascular diagnostics in everyday practice. In short, MRA's future will be defined not only by imaging performance but also by the capacity of the ecosystem to deliver accessible, reliable, and clinically integrated solutions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Magnetic Resonance Angiography Market, by Product

  • 8.1. Accessories And Consumables
  • 8.2. Service
  • 8.3. Systems
    • 8.3.1. High Field Strength System
    • 8.3.2. Low Field Strength System

9. Magnetic Resonance Angiography Market, by Field Strength

  • 9.1. High Field Strength
  • 9.2. Low Field Strength

10. Magnetic Resonance Angiography Market, by Technology

  • 10.1. Contrast Enhanced
  • 10.2. Phase Contrast
  • 10.3. Quiescent Interval Single Shot
  • 10.4. Time Of Flight

11. Magnetic Resonance Angiography Market, by Application

  • 11.1. Cardiovascular
  • 11.2. Neurovascular
  • 11.3. Peripheral Vascular

12. Magnetic Resonance Angiography Market, by End User

  • 12.1. Academic Research Institute
  • 12.2. Ambulatory Surgical Center
  • 12.3. Diagnostic Imaging Center
  • 12.4. Hospital

13. Magnetic Resonance Angiography Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Magnetic Resonance Angiography Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Magnetic Resonance Angiography Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Magnetic Resonance Angiography Market

17. China Magnetic Resonance Angiography Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ASG Superconductors S.p.A.
  • 18.6. Aspect Imaging Ltd.
  • 18.7. Aurora Imaging Technologies, Inc.
  • 18.8. Bruker Corporation
  • 18.9. Canon Medical Systems Corporation
  • 18.10. Esaote S.p.A.
  • 18.11. Fonar Corporation
  • 18.12. Fujifilm Holdings Corporation
  • 18.13. GE Healthcare, Inc.
  • 18.14. Hitachi, Ltd.
  • 18.15. Hologic, Inc.
  • 18.16. Hyperfine, Inc.
  • 18.17. Koninklijke Philips N.V.
  • 18.18. Neusoft Medical Systems Co., Ltd.
  • 18.19. Oxford Instruments plc
  • 18.20. Samsung Medison Co., Ltd.
  • 18.21. Shenzhen Anke High-tech Co., Ltd.
  • 18.22. Shimadzu Corporation
  • 18.23. Siemens Healthineers AG
  • 18.24. Time Medical Holding Co., Ltd.
  • 18.25. United Imaging Healthcare Co., Ltd.
  • 18.26. Wandong Medical Equipment Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SERVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SERVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SERVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PHASE CONTRAST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PHASE CONTRAST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PHASE CONTRAST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY QUIESCENT INTERVAL SINGLE SHOT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY QUIESCENT INTERVAL SINGLE SHOT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY QUIESCENT INTERVAL SINGLE SHOT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TIME OF FLIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TIME OF FLIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TIME OF FLIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC IMAGING CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC IMAGING CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC IMAGING CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 129. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 130. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 131. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 150. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 151. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 152. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 157. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 158. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 159. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)